| SHORT COMMUNICATION
|Year : 1996 | Volume
| Issue : 4 | Page : 231--232
Mesalazine in treatment of psoriasis
Sri Guru Ram Das and Civil Hosptials, Amritsar, India
Mesalazine- a 5 lipoxygenase inhibitor was tried in this open trial on 20 psoriatics. Whereas 50% patients (10) had complete clearance in 4 weeks, by 12 weeks 85% (17) patients had good response and 15% (3) patients had no relief at all. No side effects were observed.Further longitudinal double-blind trials of this drug, which has an advantage of not causing bone marrow depression and oligospermia over sulfasalazine, another 5 lipoxygenase inhibitor, are advocated.
424-Basant Avenue, Amritsar
Source of Support: None, Conflict of Interest: None